Profil
Philippe Mendels-Flandre is the founder of Austral DX, serving as Chief Executive Officer since 2021.
Former positions include General Manager-Emerging Markets at Shire France SAS and Chief Operating Officer at Lysogene SA from 2017 to 2018.
Education includes an undergraduate degree from The Louvain School of Management.
Postes actifs de Philippe Mendels-Flandre
| Sociétés | Poste | Début |
|---|---|---|
AUSTRAL Dx
AUSTRAL Dx Medical SpecialtiesHealth Technology Develops ultrasound-based diagnostic system for lung and cardiac diseases | Directeur Général | 01/01/2021 |
Anciens postes connus de Philippe Mendels-Flandre
| Sociétés | Poste | Fin |
|---|---|---|
| LYSOGENE | Directeur des opérations | 15/11/2018 |
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Formation de Philippe Mendels-Flandre
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lysogene SA
Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
The Louvain School of Management
The Louvain School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AUSTRAL Dx
AUSTRAL Dx Medical SpecialtiesHealth Technology Develops ultrasound-based diagnostic system for lung and cardiac diseases | Health Technology |
















